Annual Report On Essential Oils, Aromatic Chemicals and Related Materials
Dive into the early 20th-century world of fragrance and pharmaceuticals with the "Annual Report On Essential Oils, Aromatic Chemicals and Related Materials" by Schimmel & Co. This meticulously compiled report offers a comprehensive overview of the state of essential oils and aromatic chemicals. It's an invaluable resource for researchers, historians of science and medicine, and anyone interested in the historical context of pharmacology and industrial chemistry. Originally published in 1906, this report provides detailed analyses, market trends, and scientific advancements in the field. Discover the applications and sources of various essential oils and aromatic compounds, reflecting the industrial and scientific practices of the era. This historical document offers a unique glimpse into the raw materials that shaped early fragrance and pharmaceutical industries.This work has been selected by scholars as being culturally important, and is part of the knowledge base of civilization as we know it. This work was reproduced from the original artifact, and remains as true to the original work as possible. Therefore, you will see the original copyright references, library stamps (as most of these works have been housed in our most important libraries around the world), and other notations in the work.This work is in the public domain in the United States of America, and possibly other nations. Within the United States, you may freely copy and distribute this work, as no entity (individual or corporate) has a copyright on the body of the work.As a reproduction of a historical artifact, this work may contain missing or blurred pages, poor pictures, errant marks, etc. Scholars believe, and we concur, that this work is important enough to be preserved, reproduced, and made generally available to the public. We appreciate your support of the preservation process, and thank you for being an important part of keeping this knowledge alive and relevant.
Immediate and Delayed Drug Therapy Effects on Low Dose Sarin Exposed Mice Myocardial Performance
Recent studies have shown that a single asymptomatic dose exposure to the nerve agent sarin can lead to long term cardiac dysfunction. This study looked at immediate and delayed treatment therapies post exposure on cardiac function. The mice were studied using electrocardiography (QTc, STc, and Tc intervals) and histological techniques (hematoxylin and eosin staining and brain natriuretic peptide (BNP) staining). Male C57BL/6J mice were injected with sarin (0.4LD₅₀) and studied up to 11 weeks. Mice which were given a single dose of the nerve agent treatment atropine/2PAMCL, showed significantly higher cell size and BNP levels than the control (p = 0.001) and increased QTc and Tc intervals, all of which are indicators of cardiac insult . Mice which received drug treatments after the onset of cardiac remodeling showed increased (thus worsening) normalized heart size for isoproterenol (β agonist) treated mice (p = 0.0018) versus saline treated mice along with inverted T-waves pre cardiac stressing. Propranolol (β blocker) treated mice showed only T-wave depression and no difference in normalized heart size versus the saline group. These results suggest that standard treatment methods for nerve agent exposure are not effective in preventing long term cardiac dysfunction and in fact cause them.This work has been selected by scholars as being culturally important, and is part of the knowledge base of civilization as we know it. This work was reproduced from the original artifact, and remains as true to the original work as possible. Therefore, you will see the original copyright references, library stamps (as most of these works have been housed in our most important libraries around the world), and other notations in the work.This work is in the public domain in the United States of America, and possibly other nations. Within the United States, you may freely copy and distribute this work, as no entity (individual or corporate) has a copyright on the body of the work.As a reproduction of a historical artifact, this work may contain missing or blurred pages, poor pictures, errant marks, etc. Scholars believe, and we concur, that this work is important enough to be preserved, reproduced, and made generally available to the public. We appreciate your support of the preservation process, and thank you for being an important part of keeping this knowledge alive and relevant.
Pharmaceutical Surge Requirements for the Prime Vendor Program-Europe in Support of Military Operations Other Than War
The U.S. military in Europe often provides medical support to military operations other than war due to unstable situations in that region of the world. The increasing support to peace operations and humanitarian assistance have led the military medical units in Europe to reexamine the pharmaceuticals traditionally maintained to support surges. This research was a qualitative, exploratory study using multiple-case study strategy to identify the specific pharmaceuticals utilized in the initial stages of military operations other than war primarily peacekeeping, peace enforcement and humanitarian assistance. The operations chosen as the units of analysis were Operation Provide Promise (Croatia), Operation Support Hope (Rwanda), and Operation Joint Endeavor (Bosnia-Herzegovina). The results of the research show that some unique surge requirements exist for military operations other than war. Taking advantage of existing clauses in its Prime Vendor contracts, the military medical community in Europe can position itself to adequately support surges for MOOTW. Future studies can continue to build on this concept and identify pharmaceutical inventory to support a wide range of contingencies which can be maintained by commercial vendors for immediate access.This work has been selected by scholars as being culturally important, and is part of the knowledge base of civilization as we know it. This work was reproduced from the original artifact, and remains as true to the original work as possible. Therefore, you will see the original copyright references, library stamps (as most of these works have been housed in our most important libraries around the world), and other notations in the work.This work is in the public domain in the United States of America, and possibly other nations. Within the United States, you may freely copy and distribute this work, as no entity (individual or corporate) has a copyright on the body of the work.As a reproduction of a historical artifact, this work may contain missing or blurred pages, poor pictures, errant marks, etc. Scholars believe, and we concur, that this work is important enough to be preserved, reproduced, and made generally available to the public. We appreciate your support of the preservation process, and thank you for being an important part of keeping this knowledge alive and relevant.
An Update on Mechanisms and Treatments for Thyroid Cancer in Current Oncology
The incidence rate of thyroid cancer (TC) has risen sharply in recent decades on a global scale. It is the most common malignant tumor of the endocrine system, accounting for 4.1% of all new cancer cases worldwide, with age-standardized incidence rates (ASIRs) of 9.1 per 100,000 in 2022, establishing itself as a significant threat to population health. Although TC generally exhibits a better prognosis compared to other cancers, poorly differentiated thyroid cancer (including poorly differentiated TC, PDTC and anaplastic TC, ATC, two subtypes of TC) displays the shortest average survival time. The precise cause of TC's high incidence remains unclear, particularly the molecular mechanisms underlying its development. Consequently, the primary approaches for treating TC involve surgery, often supplemented by 131I therapy, radiotherapy, endocrine therapy, and biomarker-targeted therapy. Unfortunately, these treatments, except for targeted biological therapies, often result in irreversible harm to patients, such as thyroidectomy or radiation injuries. While targeted therapy can be expensive, and current TC biomarkers remain limited, their effects are still being explored. Additionally, aside from surgical resection, alternative treatment methods remain subject to ongoing controversy.
Applications of Antioxidant Nanoparticles
Reactive oxygen species (ROS) are essential in regulating various physiological functions. However, the overproduction of ROS can be related to many diseases. Antioxidant administration represents an effective strategy to treat oxidative stress. In recent decades, nanotechnology and nanoparticles have received great interest and seen applications in many fields, from pharmaceutics to cosmetics and food. For instance, lipid nanoparticles, due to their "green" characteristics related to their biodegradation and non-toxicity, have received significant attention as a carrier for antioxidant molecules. Over the past few decades, significant achievements have been made in the development of antioxidant nanotherapies, exhibiting multiple advantages.This Special Issue collects recent advances in the design, production, characterization, use, and effect of antioxidant nanoparticles, including polymeric or lipid-based nanoparticles, ROS-scavenging inorganic nanoparticles, organic nanoparticles with intrinsic antioxidant activity, and drug-loaded antioxidant nanoparticles, to be administered by different routes. In other words, articles focus on the use of antioxidant nanoparticles in the biomedical, pharmaceutical, and cosmetic field, as well as in the food sector.
Plant Secondary Metabolites
This book explores the pharmacological potential of plant secondary metabolites, discussing their diversity, biosynthesis pathways, innovative production techniques, and applications in food, cosmetics, and pharmaceutical industries. This book is useful for researchers of ethnopharmacology, pharmaceutical sciences, and biomedical sciences.
Advances in Scoliosis, Spinal Deformity and Other Spinal Disorders
The present Special Issue focuses on the management of spinal deformity, including contributions from international experts. Points of discussion include nonoperative management, instrumentation level determination, and complication prediction (e.g., infection and durotomy). Though far from being all-encompassing, this Special Issue aims to highlight ongoing areas of investigation in the management of spine deformity and should be of interest to those practicing within this field.
Neurotrauma
This Reprint presents eight peer-reviewed studies on the pathophysiology and treatment of neurotrauma. The collection addresses traumatic brain and spinal cord injuries through both mechanistic investigations and clinical applications. Its topics include the following: the effects of subanesthetic ketamine on stress hormones and synaptic density following mild traumatic brain injury; mesenchymal stem cell-derived exosomes as a potential regenerative therapy; selective COX-2 inhibitors for neuroprotection; monoclonal antibody therapies targeting post-traumatic inflammation; the implementation of artificial intelligence in traumatic brain injury management, along with its associated ethical considerations; diagnostic challenges in traumatic encephalopathy syndrome; cellular mechanisms underlying clinical outcomes in neurotrauma; and neurophysiological evidence that unilateral brachial plexus injuries affect bilateral neural transmission. The research methodologies presented in this Reprint range from rodent models to clinical neurophysiology, encompassing molecular pathways, imaging techniques, biomarker development, and therapeutic strategies. These contributions document current understanding of primary and secondary injury cascades-including inflammation, oxidative stress, and excitotoxicity-while evaluating interventions aimed at neuroprotection and regeneration. The compilation is intended to serve as a useful resource for researchers and clinicians working to improve outcomes for the millions of individuals who are affected annually by neurotrauma.
Inside Autism
Inside Autism - Integrative Approaches for a Better LifeA transformative journey through the body, mind, and emotions of autistic children, this book offers an evidence-based and deeply human guide to support families, therapists, and health professionals.Combining neuroscience, functional medicine, gut health, therapeutic touch, and clinical nutrition, Inside Autism reveals how seemingly disconnected symptoms-sleep issues, digestive distress, language delays, emotional outbursts-are often rooted in silent inflammation and metabolic imbalances.Through clear language, practical protocols, and real clinical cases, Fernando Miano invites readers to go beyond behavioral management. He presents a model of care that is sensitive, precise, and grounded in integrative science-one that listens to the body and respects each child's timing.Whether you're a parent seeking clarity or a professional looking to refine your approach, this book will help you understand: - Why behavior is often a symptom, not a cause;- How diet and gut health influence mood, speech, and cognition;- What labs matter-and what they really mean;- How to use supplements wisely, with real impact;- When and how to apply tools like photobiomodulation, vagal therapy, or cranial touch.Inside Autism is not about curing autism. It is about reducing suffering, unlocking potential, and creating environments where neurodivergent children can thrive-fully, safely, and with dignity.
Parkinson's desease, Recovery path
Idiopathic Parkinson's disease is generally described as a neurodegenerative pathology characterized by a progressive loss of dopaminergic neurons in the substantia nigra, responsible for impaired motor functions. Despite significant advances in understanding its biological mechanisms, a significant proportion of cases remain without a clearly identified organic explanation, which raising the question of other etiological avenues.In this context, the clinical work of Dr. Janice Hadlock makes an original contribution by suggesting the existence of a functional dysfunction of the dopaminergic system, not related to irreversible neuronal degeneration, but potentially reversible. This hypothesis, resulting from the observation of numerous cases in his clinical practice, calls into question the irreversible evolution of idiopathic Parkinson's disease and paves the way for a redefinition of clinical subtypes.This gives many patients hope of belonging to a reversible subtype.However, these observations have not yet been corroborated by a large-scale study, which limits their scientific significance. An in-depth multicenter survey would not only make it possible to estimate the prevalence of this functional form, but also to validate or refute the diagnostic criteria and therapeutic strategies it recommends. In the absence of such data, the distinction between organic Parkinson's and functional Parkinson's remains difficult to establish, but is plausible as also suggested by some scientific publications. The neurophysiological study of functional parkinsonian syndrome gains in depth when considering the autonomic mechanisms of the nervous system, particularly those related to fear and archaic reflexes. Building on the concept of defensive cascade, as described in article PMC4495877, ( https: //europepmc.org/article/pmc/4495877 ) it is possible to explore how these mechanisms can contribute to functional forms of the syndrome. These forms, like those observed by Dr. Hadlock, are characterized by a motor freeze and postural disorders that are not neuronal degeneration, but a neurological pattern that is incompletely reset and potentially reversible.This perspective paves the way for the integration of neurobehavioural models into the study of the disease, reinforcing the idea that functional Parkinson's could be, in a number of cases, the expression of a blockage in the defence circuits, rather than a neuronal death.Dr A. Vitiello
Multidimensional Diabetes A 360簞 Approach to Understanding & Treatment
Diabetes mellitus, often referred to simply as diabetes, is a chronic metabolic disorder characterized by elevated blood glucose levels due to defects in insulin secretion, insulin action, or both. It is a complex, multifactorial condition that impacts various organs and systems. As the global prevalence of diabetes continues to rise dramatically, it has become a significant public health issue affecting millions. The disease is not only associated with serious complications-such as cardiovascular disease, kidney failure, and blindness-but also imposes emotional, financial, and societal burdens.The history of diabetes dates back to ancient times, with early mentions in Egyptian papyri and Hindu scriptures. The term "diabetes" was coined by the Greek physician Aretaeus in the 2nd century, and it was not until the 20th century that insulin was discovered and revolutionized diabetes treatment. Today, diabetes is a leading cause of death and disability. According to the International Diabetes Federation (IDF), as of 2024, over 530 million people globally are affected, with projections indicating a rise to 640 million by 2030. India alone harbors more than 100 million diabetics.
Development of Fenoprofen Calcium Tablets for Colon Targeting
Objective: The objective of the present investigation was to development of enteric coated tablet of fenoprofen calcium. Methods: The 32factorial design was used to preparation of compression‐coated with a mixture of time dependent hydrophilic swellable polymer hydropropylcellulose (HPC), time released polymer Ethyl cellulose (EC) and pH responsive soluble polymer Instacoat EN Super II. The developed formulations were characterized for angle of repose, density, carr's index of powder mixture and thickness, diameter, hardness, friability, weight variation, uniformity content, in vitro disintegration, dissolution study. Results: The results showed that disintegration time and dissolution study of inner core tablet found to be in the range of 7.15 to 13.34 min and 95.92簣0.011% at 30 min. The press coat tablets at optimum concentrations of hydroxy propyl cellulose (200 mg) and ethyl cellulose N-22 (200 mg) showed the % drug release 83.53簣0.014% at 12 hr. % cumulative drug release of enteric coated tablet of optimized batch FT9 showed 76.08簣0.045 at 12h, it indicated that drug release at sustained manner.
Characteristic Materia Medica Memorizer
"Characteristic Materia Medica Memorizer" by William H. Burt, originally published in 1895, serves as a comprehensive guide to homeopathic materia medica. This book is designed to aid practitioners and students in memorizing and understanding the key characteristics of various homeopathic remedies. Organized for quick reference, it details the specific symptoms and conditions each remedy is best suited to address. Burt's work reflects the state of homeopathic practice in the late 19th century, offering insights into the remedies commonly used during that era. It remains a valuable resource for those interested in the history of homeopathy and the traditional methods of remedy selection. "Characteristic Materia Medica Memorizer" provides a unique glimpse into the therapeutic approaches of the past and continues to be studied by contemporary homeopaths and historians of medicine.This work has been selected by scholars as being culturally important, and is part of the knowledge base of civilization as we know it. This work was reproduced from the original artifact, and remains as true to the original work as possible. Therefore, you will see the original copyright references, library stamps (as most of these works have been housed in our most important libraries around the world), and other notations in the work.This work is in the public domain in the United States of America, and possibly other nations. Within the United States, you may freely copy and distribute this work, as no entity (individual or corporate) has a copyright on the body of the work.As a reproduction of a historical artifact, this work may contain missing or blurred pages, poor pictures, errant marks, etc. Scholars believe, and we concur, that this work is important enough to be preserved, reproduced, and made generally available to the public. We appreciate your support of the preservation process, and thank you for being an important part of keeping this knowledge alive and relevant.
The Homopathic Treatment of Syphilis, Gonorrha, Spermatorrha, and Urinary Diseases
"The Homopathic Treatment of Syphilis, Gonorrha, Spermatorrha, and Urinary Diseases" offers a detailed exploration of homeopathic approaches to treating various venereal and urinary ailments prevalent in the 19th century. Penned by Jean Philibert Berjeau and edited by James Henry Paine Frost, this historical medical text provides insights into the diagnostic methods and therapeutic interventions utilized within the homeopathic tradition during this era. The book delves into the specifics of syphilis, gonorrhea, spermatorrhea, and a range of urinary diseases, presenting case studies and treatment protocols that reflect the medical knowledge and practices of the time. This volume serves as a valuable resource for historians of medicine, homeopathic practitioners, and anyone interested in the evolution of medical treatments for sexually transmitted and urinary conditions.This work has been selected by scholars as being culturally important, and is part of the knowledge base of civilization as we know it. This work was reproduced from the original artifact, and remains as true to the original work as possible. Therefore, you will see the original copyright references, library stamps (as most of these works have been housed in our most important libraries around the world), and other notations in the work.This work is in the public domain in the United States of America, and possibly other nations. Within the United States, you may freely copy and distribute this work, as no entity (individual or corporate) has a copyright on the body of the work.As a reproduction of a historical artifact, this work may contain missing or blurred pages, poor pictures, errant marks, etc. Scholars believe, and we concur, that this work is important enough to be preserved, reproduced, and made generally available to the public. We appreciate your support of the preservation process, and thank you for being an important part of keeping this knowledge alive and relevant.
Concussion Management Guideline
The Colorado State Publications Library (CoSPL) was established by the General Assembly in 1980 as a part of the Colorado State Library and the Colorado Department of Education. The mission of the library is to provide Colorado residents with permanent public access to information produced by state government. The state publications are valuable sources of information published by Colorado state agencies that include annual reports, budgets, planning reports, consumer information, legislative reports and directories. The publications cover a wide variety of topics including health, business, education, crime, agriculture, mining, employment, taxes, water quality, wildlife and the environment. This publication is one in this collection.This work has been selected by scholars as being culturally important, and is part of the knowledge base of civilization as we know it. This work was reproduced from the original artifact, and remains as true to the original work as possible. Therefore, you will see the original copyright references, library stamps (as most of these works have been housed in our most important libraries around the world), and other notations in the work.This work is in the public domain in the United States of America, and possibly other nations. Within the United States, you may freely copy and distribute this work, as no entity (individual or corporate) has a copyright on the body of the work.As a reproduction of a historical artifact, this work may contain missing or blurred pages, poor pictures, errant marks, etc. Scholars believe, and we concur, that this work is important enough to be preserved, reproduced, and made generally available to the public. We appreciate your support of the preservation process, and thank you for being an important part of keeping this knowledge alive and relevant.
Dichloroacetic Acid
The U.S. Environmental Protection Agency (EPA) was introduced on December 2, 1970 by President Richard Nixon. The agency is charged with protecting human health and the environment, by writing and enforcing regulations based on laws passed by Congress. The EPA's struggle to protect health and the environment is seen through each of its official publications. These publications outline new policies, detail problems with enforcing laws, document the need for new legislation, and describe new tactics to use to solve these issues. This collection of publications ranges from historic documents to reports released in the new millennium, and features works like: Bicycle for a Better Environment, Health Effects of Increasing Sulfur Oxides Emissions Draft, and Women and Environmental Health.This work has been selected by scholars as being culturally important, and is part of the knowledge base of civilization as we know it. This work was reproduced from the original artifact, and remains as true to the original work as possible. Therefore, you will see the original copyright references, library stamps (as most of these works have been housed in our most important libraries around the world), and other notations in the work.This work is in the public domain in the United States of America, and possibly other nations. Within the United States, you may freely copy and distribute this work, as no entity (individual or corporate) has a copyright on the body of the work.As a reproduction of a historical artifact, this work may contain missing or blurred pages, poor pictures, errant marks, etc. Scholars believe, and we concur, that this work is important enough to be preserved, reproduced, and made generally available to the public. We appreciate your support of the preservation process, and thank you for being an important part of keeping this knowledge alive and relevant.
Optimization of Therapeutic Strategies for Organophosphate Poisoning
The National Preparedness Vision requires the U.S. be prepared to prevent, protect against, respond to, and recover from all hazards associated with a chemical attack. Results of this study demonstrate that we cannot protect service members and first responders as required following a nerve agent attack. The research presented herein aimed to construct a physiologically based pharmacokinetic model to determine optimal therapeutic strategies for organophosphate (nerve agent) poisoning. The constructed model integrated organophosphates and two antidotes, atropine and oximes. Model results reasonably mirrored literature data and anecdotal observations of organophosphate poisoning. Results suggest a symptoms-based dosing strategy of atropine and a time-based dosing strategy of oximes. For patients severely poisoned with organophosphorus nerve agents, model results support documented claims of oxime's inefficacy and tendency to heighten the severity of poisoning. The results strongly indicate that military personnel attacked with nerve agents are at a significant health risk if they employ their prescribed treatment as current doctrine dictates. Results presented herein suggest that oxime use be discontinued as currently prescribed within the context of nerve agent exposure; its use will not alter the effects of nerve agent exposure and may increase the adverse effects.This work has been selected by scholars as being culturally important, and is part of the knowledge base of civilization as we know it. This work was reproduced from the original artifact, and remains as true to the original work as possible. Therefore, you will see the original copyright references, library stamps (as most of these works have been housed in our most important libraries around the world), and other notations in the work.This work is in the public domain in the United States of America, and possibly other nations. Within the United States, you may freely copy and distribute this work, as no entity (individual or corporate) has a copyright on the body of the work.As a reproduction of a historical artifact, this work may contain missing or blurred pages, poor pictures, errant marks, etc. Scholars believe, and we concur, that this work is important enough to be preserved, reproduced, and made generally available to the public. We appreciate your support of the preservation process, and thank you for being an important part of keeping this knowledge alive and relevant.
USAF Civil Reserve Air Fleet Aeromedical Evacuation Airlift Capability
The Department of Defense, USAF, and Air Mobility Command (AMC) rely on the Civil Reserve Air Fleet (CRAF) to provide supplemental airlift in times of national emergency. AMC oversees the CRAF program which contains three segments: international, national, and aeromedical evacuation. The CRAF Aeromedical Evacuation (AE) program involves commercial B-767 aircraft, Aeromedical Evacuation Shipsets (AESS), a Casualty Transfer System, and a large number of support personnel and equipment. Wartime planning in the early 1980s revealed a significant shortage of military airlift to accomplish the aeromedical evacuation mission. Consequently the CRAF AE program was initiated. Planning for Major Regional Conflict scenarios has currently set a requirement for 25 and 44 B-767 aircraft for CRAF Stages II and III, respectively. Unfortunately AMC has not been able to acquire full commitment to the CRAF AE program.This work has been selected by scholars as being culturally important, and is part of the knowledge base of civilization as we know it. This work was reproduced from the original artifact, and remains as true to the original work as possible. Therefore, you will see the original copyright references, library stamps (as most of these works have been housed in our most important libraries around the world), and other notations in the work.This work is in the public domain in the United States of America, and possibly other nations. Within the United States, you may freely copy and distribute this work, as no entity (individual or corporate) has a copyright on the body of the work.As a reproduction of a historical artifact, this work may contain missing or blurred pages, poor pictures, errant marks, etc. Scholars believe, and we concur, that this work is important enough to be preserved, reproduced, and made generally available to the public. We appreciate your support of the preservation process, and thank you for being an important part of keeping this knowledge alive and relevant.
Guidelines for Neurotoxicity Risk Assessment
The U.S. Environmental Protection Agency (EPA) was introduced on December 2, 1970 by President Richard Nixon. The agency is charged with protecting human health and the environment, by writing and enforcing regulations based on laws passed by Congress. The EPA's struggle to protect health and the environment is seen through each of its official publications. These publications outline new policies, detail problems with enforcing laws, document the need for new legislation, and describe new tactics to use to solve these issues. This collection of publications ranges from historic documents to reports released in the new millennium, and features works like: Bicycle for a Better Environment, Health Effects of Increasing Sulfur Oxides Emissions Draft, and Women and Environmental Health.This work has been selected by scholars as being culturally important, and is part of the knowledge base of civilization as we know it. This work was reproduced from the original artifact, and remains as true to the original work as possible. Therefore, you will see the original copyright references, library stamps (as most of these works have been housed in our most important libraries around the world), and other notations in the work.This work is in the public domain in the United States of America, and possibly other nations. Within the United States, you may freely copy and distribute this work, as no entity (individual or corporate) has a copyright on the body of the work.As a reproduction of a historical artifact, this work may contain missing or blurred pages, poor pictures, errant marks, etc. Scholars believe, and we concur, that this work is important enough to be preserved, reproduced, and made generally available to the public. We appreciate your support of the preservation process, and thank you for being an important part of keeping this knowledge alive and relevant.
Managing the DoD Pharmacy Benefit in the 21st Century
The provision of military medical care across the Department of Defense stands on the cusp of immense change, especially the Pharmacy benefit. Changes in civilian and military policies and procedures, escalation in pharmacy benefit utilization, and increasing medication costs are transforming pharmacy benefit structure and the face of the personnel that provide the pharmacy benefit. Medical breakthroughs are expensive and the DoD, along with the entire US health care system, must astutely manage health care expenditures. This research paper will explore the issues affecting the provision of the DoD pharmacy benefit and attempt to determine the most cost-effective venue for providing this benefit. The primary focus will be the differences between the Military Treatment Facility (MTF) and Tricare Retail Network Pharmacy (TRRx). The Tricare Mail Order Pharmacy (TMOP) is near cost neutral to the MTF, (because the dispensing fee is partially offset by the $3/$9 co-pays) therefore it is excluded from comparisons in this paper. The TMOP's only utility is refilling maintenance medications. It cannot be used to fill acute medication prescriptions like antibiotics. Data from literature sources, the DoD Pharmacoeconomic Center (PEC), and the Pharmacy Data Transaction Service (PDTS) will be used in a retrospective methodology to estimate the most cost-effective venue for providing the DoD pharmacy benefit. This analysis utilizes well-defined, common data points such as medication ingredient costs and number of prescriptions dispensed as well as more nebulous data points like prescription dispensing costs and personnel costs.This work has been selected by scholars as being culturally important, and is part of the knowledge base of civilization as we know it. This work was reproduced from the original artifact, and remains as true to the original work as possible. Therefore, you will see the original copyright references, library stamps (as most of these works have been housed in our most important libraries around the world), and other notations in the work.This work is in the public domain in the United States of America, and possibly other nations. Within the United States, you may freely copy and distribute this work, as no entity (individual or corporate) has a copyright on the body of the work.As a reproduction of a historical artifact, this work may contain missing or blurred pages, poor pictures, errant marks, etc. Scholars believe, and we concur, that this work is important enough to be preserved, reproduced, and made generally available to the public. We appreciate your support of the preservation process, and thank you for being an important part of keeping this knowledge alive and relevant.
Registry of Toxic Effects of Chemical Substances (RTECS)
This Comprehensive Guide to the Registry of Toxic Effects of Chemical Substances (RTECS?(R)) describes the types of data, and their format, contained in the January 1997 update of the RTECS?(R). Since this Guide was issued in 1993, there have been a few changes that will be discussed in this volume.This work has been selected by scholars as being culturally important, and is part of the knowledge base of civilization as we know it. This work was reproduced from the original artifact, and remains as true to the original work as possible. Therefore, you will see the original copyright references, library stamps (as most of these works have been housed in our most important libraries around the world), and other notations in the work.This work is in the public domain in the United States of America, and possibly other nations. Within the United States, you may freely copy and distribute this work, as no entity (individual or corporate) has a copyright on the body of the work.As a reproduction of a historical artifact, this work may contain missing or blurred pages, poor pictures, errant marks, etc. Scholars believe, and we concur, that this work is important enough to be preserved, reproduced, and made generally available to the public. We appreciate your support of the preservation process, and thank you for being an important part of keeping this knowledge alive and relevant.
Adulterated Drugs and Chemicals. I. Inferior Drugs and Insidious Methods of Deception. II. Rose Geranium Oil and Its Substitutes. III. Phenacetin
Adulterated Drugs and Chemicals is a crucial early 20th-century work addressing the pervasive issues of drug adulteration and deceptive practices within the pharmaceutical industry. This comprehensive volume, divided into three key sections, meticulously examines inferior drugs, insidious methods of deception, and the commercial status of essential pharmaceutical ingredients. The first section focuses on identifying inferior drugs and exposes the fraudulent techniques used to deceive consumers. The second delves into the substitutes and adulterants found in rose geranium oil, a widely used ingredient. Finally, the study provides a detailed analysis of phenacetin, an analgesic drug, including its methods of analysis and commercial status. This historical text is invaluable for researchers, historians, and anyone interested in the origins of pharmaceutical regulation and the challenges of ensuring drug quality and authenticity. It offers insights into the early practices of drug manufacturing and provides a stark reminder of the importance of rigorous quality control in the pharmaceutical industry.This work has been selected by scholars as being culturally important, and is part of the knowledge base of civilization as we know it. This work was reproduced from the original artifact, and remains as true to the original work as possible. Therefore, you will see the original copyright references, library stamps (as most of these works have been housed in our most important libraries around the world), and other notations in the work.This work is in the public domain in the United States of America, and possibly other nations. Within the United States, you may freely copy and distribute this work, as no entity (individual or corporate) has a copyright on the body of the work.As a reproduction of a historical artifact, this work may contain missing or blurred pages, poor pictures, errant marks, etc. Scholars believe, and we concur, that this work is important enough to be preserved, reproduced, and made generally available to the public. We appreciate your support of the preservation process, and thank you for being an important part of keeping this knowledge alive and relevant.
Characteristic Materia Medica Memorizer
"Characteristic Materia Medica Memorizer" by William H. Burt, originally published in 1895, serves as a comprehensive guide to homeopathic materia medica. This book is designed to aid practitioners and students in memorizing and understanding the key characteristics of various homeopathic remedies. Organized for quick reference, it details the specific symptoms and conditions each remedy is best suited to address. Burt's work reflects the state of homeopathic practice in the late 19th century, offering insights into the remedies commonly used during that era. It remains a valuable resource for those interested in the history of homeopathy and the traditional methods of remedy selection. "Characteristic Materia Medica Memorizer" provides a unique glimpse into the therapeutic approaches of the past and continues to be studied by contemporary homeopaths and historians of medicine.This work has been selected by scholars as being culturally important, and is part of the knowledge base of civilization as we know it. This work was reproduced from the original artifact, and remains as true to the original work as possible. Therefore, you will see the original copyright references, library stamps (as most of these works have been housed in our most important libraries around the world), and other notations in the work.This work is in the public domain in the United States of America, and possibly other nations. Within the United States, you may freely copy and distribute this work, as no entity (individual or corporate) has a copyright on the body of the work.As a reproduction of a historical artifact, this work may contain missing or blurred pages, poor pictures, errant marks, etc. Scholars believe, and we concur, that this work is important enough to be preserved, reproduced, and made generally available to the public. We appreciate your support of the preservation process, and thank you for being an important part of keeping this knowledge alive and relevant.
The Homopathic Treatment of Syphilis, Gonorrha, Spermatorrha, and Urinary Diseases
"The Homopathic Treatment of Syphilis, Gonorrha, Spermatorrha, and Urinary Diseases" offers a detailed exploration of homeopathic approaches to treating various venereal and urinary ailments prevalent in the 19th century. Penned by Jean Philibert Berjeau and edited by James Henry Paine Frost, this historical medical text provides insights into the diagnostic methods and therapeutic interventions utilized within the homeopathic tradition during this era. The book delves into the specifics of syphilis, gonorrhea, spermatorrhea, and a range of urinary diseases, presenting case studies and treatment protocols that reflect the medical knowledge and practices of the time. This volume serves as a valuable resource for historians of medicine, homeopathic practitioners, and anyone interested in the evolution of medical treatments for sexually transmitted and urinary conditions.This work has been selected by scholars as being culturally important, and is part of the knowledge base of civilization as we know it. This work was reproduced from the original artifact, and remains as true to the original work as possible. Therefore, you will see the original copyright references, library stamps (as most of these works have been housed in our most important libraries around the world), and other notations in the work.This work is in the public domain in the United States of America, and possibly other nations. Within the United States, you may freely copy and distribute this work, as no entity (individual or corporate) has a copyright on the body of the work.As a reproduction of a historical artifact, this work may contain missing or blurred pages, poor pictures, errant marks, etc. Scholars believe, and we concur, that this work is important enough to be preserved, reproduced, and made generally available to the public. We appreciate your support of the preservation process, and thank you for being an important part of keeping this knowledge alive and relevant.
Optimization of Therapeutic Strategies for Organophosphate Poisoning
The National Preparedness Vision requires the U.S. be prepared to prevent, protect against, respond to, and recover from all hazards associated with a chemical attack. Results of this study demonstrate that we cannot protect service members and first responders as required following a nerve agent attack. The research presented herein aimed to construct a physiologically based pharmacokinetic model to determine optimal therapeutic strategies for organophosphate (nerve agent) poisoning. The constructed model integrated organophosphates and two antidotes, atropine and oximes. Model results reasonably mirrored literature data and anecdotal observations of organophosphate poisoning. Results suggest a symptoms-based dosing strategy of atropine and a time-based dosing strategy of oximes. For patients severely poisoned with organophosphorus nerve agents, model results support documented claims of oxime's inefficacy and tendency to heighten the severity of poisoning. The results strongly indicate that military personnel attacked with nerve agents are at a significant health risk if they employ their prescribed treatment as current doctrine dictates. Results presented herein suggest that oxime use be discontinued as currently prescribed within the context of nerve agent exposure; its use will not alter the effects of nerve agent exposure and may increase the adverse effects.This work has been selected by scholars as being culturally important, and is part of the knowledge base of civilization as we know it. This work was reproduced from the original artifact, and remains as true to the original work as possible. Therefore, you will see the original copyright references, library stamps (as most of these works have been housed in our most important libraries around the world), and other notations in the work.This work is in the public domain in the United States of America, and possibly other nations. Within the United States, you may freely copy and distribute this work, as no entity (individual or corporate) has a copyright on the body of the work.As a reproduction of a historical artifact, this work may contain missing or blurred pages, poor pictures, errant marks, etc. Scholars believe, and we concur, that this work is important enough to be preserved, reproduced, and made generally available to the public. We appreciate your support of the preservation process, and thank you for being an important part of keeping this knowledge alive and relevant.
First Aid in Illness and Injury;
"First Aid in Illness and Injury" is a comprehensive guide to providing immediate medical assistance, written by James Evelyn Pilcher and originally published in 1899. This historical text offers invaluable insights into the medical practices and knowledge of the late 19th century, detailing essential techniques and procedures for handling various illnesses and injuries. Aimed at both medical professionals and laypersons, the book covers a wide range of topics, from basic wound care to more complex emergency interventions.Pilcher's clear and concise instructions make this book a valuable resource for anyone interested in the history of medicine or seeking practical advice on first aid. It provides a fascinating glimpse into the past, showcasing the challenges and innovations in medical care during a time when modern medical facilities were not always readily available. This edition preserves the original text, ensuring its historical and educational value for contemporary readers.This work has been selected by scholars as being culturally important, and is part of the knowledge base of civilization as we know it. This work was reproduced from the original artifact, and remains as true to the original work as possible. Therefore, you will see the original copyright references, library stamps (as most of these works have been housed in our most important libraries around the world), and other notations in the work.This work is in the public domain in the United States of America, and possibly other nations. Within the United States, you may freely copy and distribute this work, as no entity (individual or corporate) has a copyright on the body of the work.As a reproduction of a historical artifact, this work may contain missing or blurred pages, poor pictures, errant marks, etc. Scholars believe, and we concur, that this work is important enough to be preserved, reproduced, and made generally available to the public. We appreciate your support of the preservation process, and thank you for being an important part of keeping this knowledge alive and relevant.
Fenner's Formulary
"Fenner's Formulary" is a comprehensive collection of pharmaceutical formulas and preparations from the late 19th century. Compiled by Byron Fenner, this formulary offers a detailed look into the practices and ingredients used by pharmacists and apothecaries of the time. This historical text provides insight into the composition and application of various medicinal compounds, offering a valuable resource for historians of medicine, pharmaceutical researchers, and anyone interested in the evolution of healthcare practices. It is a fascinating glimpse into the world of traditional medicine and the formulas that shaped it.This work has been selected by scholars as being culturally important, and is part of the knowledge base of civilization as we know it. This work was reproduced from the original artifact, and remains as true to the original work as possible. Therefore, you will see the original copyright references, library stamps (as most of these works have been housed in our most important libraries around the world), and other notations in the work.This work is in the public domain in the United States of America, and possibly other nations. Within the United States, you may freely copy and distribute this work, as no entity (individual or corporate) has a copyright on the body of the work.As a reproduction of a historical artifact, this work may contain missing or blurred pages, poor pictures, errant marks, etc. Scholars believe, and we concur, that this work is important enough to be preserved, reproduced, and made generally available to the public. We appreciate your support of the preservation process, and thank you for being an important part of keeping this knowledge alive and relevant.
The Use of Stimulant Medication to Enhance Human Performance in Extended Military Operations
The technological ability to operate around the clock places considerable demands on military personnel as they attempt to adapt to military operations beyond normal human physiological capability. The combination of increased operations tempo, decreased military personnel, and the probability of a prolonged effort in the global war on terrorism, increase the likelihood of military personnel working extended hours. These conditions result in military personnel experiencing fatigue and a decline in performance. Military leaders have authorized certain military personnel to use stimulant medications to mitigate the effects of sleep deprivation when adequate rest periods are not possible. The administration of these stimulant medications has enabled military personnel to perform at or near their rested performance levels. Medications currently in use have side effects and have limited utility for some personnel because of those side effects. This paper supports the effectiveness and suitability of a new medication, modafanil, as an alertness enhancing medication for military personnel in a variety of operational environments. The side effect profile of modafanil is superior to agents currently in use. Modafanil should be prescribed as a first line medication for mitigation of performance decrements in sleep deprived military personnel and those who experience shift work sleep disorder.This work has been selected by scholars as being culturally important, and is part of the knowledge base of civilization as we know it. This work was reproduced from the original artifact, and remains as true to the original work as possible. Therefore, you will see the original copyright references, library stamps (as most of these works have been housed in our most important libraries around the world), and other notations in the work.This work is in the public domain in the United States of America, and possibly other nations. Within the United States, you may freely copy and distribute this work, as no entity (individual or corporate) has a copyright on the body of the work.As a reproduction of a historical artifact, this work may contain missing or blurred pages, poor pictures, errant marks, etc. Scholars believe, and we concur, that this work is important enough to be preserved, reproduced, and made generally available to the public. We appreciate your support of the preservation process, and thank you for being an important part of keeping this knowledge alive and relevant.
Registry of Toxic Effects of Chemical Substances (RTECS)
This Comprehensive Guide to the Registry of Toxic Effects of Chemical Substances (RTECS?(R)) describes the types of data, and their format, contained in the January 1997 update of the RTECS?(R). Since this Guide was issued in 1993, there have been a few changes that will be discussed in this volume.This work has been selected by scholars as being culturally important, and is part of the knowledge base of civilization as we know it. This work was reproduced from the original artifact, and remains as true to the original work as possible. Therefore, you will see the original copyright references, library stamps (as most of these works have been housed in our most important libraries around the world), and other notations in the work.This work is in the public domain in the United States of America, and possibly other nations. Within the United States, you may freely copy and distribute this work, as no entity (individual or corporate) has a copyright on the body of the work.As a reproduction of a historical artifact, this work may contain missing or blurred pages, poor pictures, errant marks, etc. Scholars believe, and we concur, that this work is important enough to be preserved, reproduced, and made generally available to the public. We appreciate your support of the preservation process, and thank you for being an important part of keeping this knowledge alive and relevant.
Guidelines for Neurotoxicity Risk Assessment
The U.S. Environmental Protection Agency (EPA) was introduced on December 2, 1970 by President Richard Nixon. The agency is charged with protecting human health and the environment, by writing and enforcing regulations based on laws passed by Congress. The EPA's struggle to protect health and the environment is seen through each of its official publications. These publications outline new policies, detail problems with enforcing laws, document the need for new legislation, and describe new tactics to use to solve these issues. This collection of publications ranges from historic documents to reports released in the new millennium, and features works like: Bicycle for a Better Environment, Health Effects of Increasing Sulfur Oxides Emissions Draft, and Women and Environmental Health.This work has been selected by scholars as being culturally important, and is part of the knowledge base of civilization as we know it. This work was reproduced from the original artifact, and remains as true to the original work as possible. Therefore, you will see the original copyright references, library stamps (as most of these works have been housed in our most important libraries around the world), and other notations in the work.This work is in the public domain in the United States of America, and possibly other nations. Within the United States, you may freely copy and distribute this work, as no entity (individual or corporate) has a copyright on the body of the work.As a reproduction of a historical artifact, this work may contain missing or blurred pages, poor pictures, errant marks, etc. Scholars believe, and we concur, that this work is important enough to be preserved, reproduced, and made generally available to the public. We appreciate your support of the preservation process, and thank you for being an important part of keeping this knowledge alive and relevant.
USAF Civil Reserve Air Fleet Aeromedical Evacuation Airlift Capability
The Department of Defense, USAF, and Air Mobility Command (AMC) rely on the Civil Reserve Air Fleet (CRAF) to provide supplemental airlift in times of national emergency. AMC oversees the CRAF program which contains three segments: international, national, and aeromedical evacuation. The CRAF Aeromedical Evacuation (AE) program involves commercial B-767 aircraft, Aeromedical Evacuation Shipsets (AESS), a Casualty Transfer System, and a large number of support personnel and equipment. Wartime planning in the early 1980s revealed a significant shortage of military airlift to accomplish the aeromedical evacuation mission. Consequently the CRAF AE program was initiated. Planning for Major Regional Conflict scenarios has currently set a requirement for 25 and 44 B-767 aircraft for CRAF Stages II and III, respectively. Unfortunately AMC has not been able to acquire full commitment to the CRAF AE program.This work has been selected by scholars as being culturally important, and is part of the knowledge base of civilization as we know it. This work was reproduced from the original artifact, and remains as true to the original work as possible. Therefore, you will see the original copyright references, library stamps (as most of these works have been housed in our most important libraries around the world), and other notations in the work.This work is in the public domain in the United States of America, and possibly other nations. Within the United States, you may freely copy and distribute this work, as no entity (individual or corporate) has a copyright on the body of the work.As a reproduction of a historical artifact, this work may contain missing or blurred pages, poor pictures, errant marks, etc. Scholars believe, and we concur, that this work is important enough to be preserved, reproduced, and made generally available to the public. We appreciate your support of the preservation process, and thank you for being an important part of keeping this knowledge alive and relevant.
Dosage Calculations Made Easy for Nursing Students
Dosage Calculations Made Easy for Nursing Students 500+ Step-by-Step Practice Problems with Complete Solutions and Explanations Are you a nursing student struggling with medication math and dreading your next dosage calculation exam? Master dosage calculations the safe and easy way with this comprehensive workbook featuring 500+ practice problems designed specifically for nursing students. This step-by-step guide transforms complex calculations into simple, manageable processes that build your confidence from basic math review through advanced clinical scenarios. Inside this essential nursing companion, you'll discover: Three proven calculation methods (dimensional analysis, ratio-proportion, and formula method)t explained in clear, anxiety-reducing language 500+ practice problems with complete solutions and detailed explanations for every step Progressive difficulty levels starting with basic conversions and advancing to complex IV drip rates and pediatric dosing Real clinical scenarios that prepare you for actual nursing practice, not just exams NCLEX-style questions aligned with current testing standards to boost your exam readiness Common medication errors and how to avoid them, ensuring patient safety in your future practice Quick reference charts for conversions, abbreviations, and formulas you'll use daily Unlike other overwhelming textbooks, this guide addresses math anxiety head-on with encouraging explanations and multiple approaches to solve each problem type. Each chapter builds systematically on previous concepts, ensuring you never feel lost or overwhelmed. Perfect for: Nursing students at all levels (LPN, ADN, BSN, MSN) NCLEX-RN and NCLEX-PN exam preparation Practicing nurses seeking a comprehensive refresher Nursing educators looking for supplemental teaching resources Transform your calculation skills and walk into your exams with confidence. Join thousands of nursing students who have conquered their math fears and mastered medication calculations using this proven approach.
Therapeutics of Homopathy;
Therapeutics of Hom?"opathy; presents a detailed exploration into the principles and practices of homeopathic medicine. Written by Ernst Ferdinand R?1/4ckert and translated by Charles Julius Hempel, this comprehensive guide delves into the therapeutic applications of homeopathy, offering insights into the treatment of various ailments through homeopathic remedies. Originally published in 1846, the book provides a thorough examination of homeopathic philosophy and its practical implementation. It serves as a valuable resource for understanding the historical context and methodologies of homeopathic treatment, appealing to both practitioners and those interested in the history of alternative medicine.This work has been selected by scholars as being culturally important, and is part of the knowledge base of civilization as we know it. This work was reproduced from the original artifact, and remains as true to the original work as possible. Therefore, you will see the original copyright references, library stamps (as most of these works have been housed in our most important libraries around the world), and other notations in the work.This work is in the public domain in the United States of America, and possibly other nations. Within the United States, you may freely copy and distribute this work, as no entity (individual or corporate) has a copyright on the body of the work.As a reproduction of a historical artifact, this work may contain missing or blurred pages, poor pictures, errant marks, etc. Scholars believe, and we concur, that this work is important enough to be preserved, reproduced, and made generally available to the public. We appreciate your support of the preservation process, and thank you for being an important part of keeping this knowledge alive and relevant.
Journal Of Homoeopathics
Explore the world of 19th-century homeopathic medicine with "Journal Of Homoeopathics, Volume 3." This historical journal offers a fascinating glimpse into the practices, theories, and debates surrounding homeopathy during a pivotal period in its development. Compiled anonymously, this volume provides insights into the remedies, case studies, and philosophical underpinnings that defined the field. This journal is a valuable resource for historians of medicine, students of alternative therapies, and anyone interested in the evolution of healthcare practices. Delve into the original texts and discover the rich history of homeopathic thought and its impact on medical treatment.This work has been selected by scholars as being culturally important, and is part of the knowledge base of civilization as we know it. This work was reproduced from the original artifact, and remains as true to the original work as possible. Therefore, you will see the original copyright references, library stamps (as most of these works have been housed in our most important libraries around the world), and other notations in the work.This work is in the public domain in the United States of America, and possibly other nations. Within the United States, you may freely copy and distribute this work, as no entity (individual or corporate) has a copyright on the body of the work.As a reproduction of a historical artifact, this work may contain missing or blurred pages, poor pictures, errant marks, etc. Scholars believe, and we concur, that this work is important enough to be preserved, reproduced, and made generally available to the public. We appreciate your support of the preservation process, and thank you for being an important part of keeping this knowledge alive and relevant.
Aeromedical Evacuation
Modern aeromedical evacuation finds it roots grounded on the lessons learned during the first global war with fully integrated airpower...World War II. During this war, the Army Air Forces created aeromedical evacuation not only out of moral obligation, but also out of necessity. Wounded soldiers, sailors, marines, and airmen needed evacuation over long distances from distant battlefields to reach adequate medical care. The sheer number of casualties drove the need for a robust, efficient aeromedical evacuation system. During the maturation of aeromedical evacuation operations, the Army Air Forces learned several, hard-fought lessons concerning multi-purpose cargo aircraft with standardized equipment, organization, and the command and control of air mobility forces conducting aeromedical evacuation. These lessons learned are still very pertinent in today's combat environment as well as for aeromedical operations in the future.This work has been selected by scholars as being culturally important, and is part of the knowledge base of civilization as we know it. This work was reproduced from the original artifact, and remains as true to the original work as possible. Therefore, you will see the original copyright references, library stamps (as most of these works have been housed in our most important libraries around the world), and other notations in the work.This work is in the public domain in the United States of America, and possibly other nations. Within the United States, you may freely copy and distribute this work, as no entity (individual or corporate) has a copyright on the body of the work.As a reproduction of a historical artifact, this work may contain missing or blurred pages, poor pictures, errant marks, etc. Scholars believe, and we concur, that this work is important enough to be preserved, reproduced, and made generally available to the public. We appreciate your support of the preservation process, and thank you for being an important part of keeping this knowledge alive and relevant.
Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction
Offers guidelines to physicians using buprenorphine for the medication-assisted treatment of opioid addiction. Explains the pharmacology of buprenorphine, patient assessment, treatment protocols, needs of special populations, and policies and procedures.This work has been selected by scholars as being culturally important, and is part of the knowledge base of civilization as we know it. This work was reproduced from the original artifact, and remains as true to the original work as possible. Therefore, you will see the original copyright references, library stamps (as most of these works have been housed in our most important libraries around the world), and other notations in the work.This work is in the public domain in the United States of America, and possibly other nations. Within the United States, you may freely copy and distribute this work, as no entity (individual or corporate) has a copyright on the body of the work.As a reproduction of a historical artifact, this work may contain missing or blurred pages, poor pictures, errant marks, etc. Scholars believe, and we concur, that this work is important enough to be preserved, reproduced, and made generally available to the public. We appreciate your support of the preservation process, and thank you for being an important part of keeping this knowledge alive and relevant.
A Treatise Of The Materia Medica And Therapeutics
"A Treatise Of The Materia Medica And Therapeutics, Volume 1" by John Eberle offers a comprehensive overview of medicinal substances and their therapeutic applications. This volume provides detailed descriptions of various drugs and their effects on the human body, reflecting the medical knowledge and practices of the time. Eberle's work is an invaluable resource for understanding the history of pharmacology and the evolution of medical treatments. It provides insights into the methods used to diagnose and treat diseases in the 19th century. This historical text is essential for anyone interested in the history of medicine, pharmacology, and therapeutic practices.This work has been selected by scholars as being culturally important, and is part of the knowledge base of civilization as we know it. This work was reproduced from the original artifact, and remains as true to the original work as possible. Therefore, you will see the original copyright references, library stamps (as most of these works have been housed in our most important libraries around the world), and other notations in the work.This work is in the public domain in the United States of America, and possibly other nations. Within the United States, you may freely copy and distribute this work, as no entity (individual or corporate) has a copyright on the body of the work.As a reproduction of a historical artifact, this work may contain missing or blurred pages, poor pictures, errant marks, etc. Scholars believe, and we concur, that this work is important enough to be preserved, reproduced, and made generally available to the public. We appreciate your support of the preservation process, and thank you for being an important part of keeping this knowledge alive and relevant.
Introduction to Chronopharmacology
The book provides the detail introduction of Chronopharmacology. Chronopharmacology is the study of how biological rhythms, such as circadian rhythms, influence the absorption, distribution, metabolism, and effects of drugs. It examines the timing of drug administration and its impact on efficacy, safety, and patient outcomes.The book itself describes the pharmacokinetic and pharmacodynamics process invlove in chronopharmacology. It also gives the detail information of chronotoxicology, biological clocks how they affect the chronopharmacology. The book describes the applications and various challenges and future Perspectives in chronopharmacology.
Recent Advances in Molecular Mechanisms Underlying Kidney Diseases
Kidney diseases remain a major public health concern associated with increasing morbidity and the mortality of millions of people globally. Recently, the prevalence of kidney diseases has increased significantly. Their pathological hallmarks include the excessive accumulation and deposition of the extracellular matrix, mesangiolysis, the thickening of the glomerular basement membrane, tubulointerstitial fibrosis, and many more, which eventually lead to the loss of kidney function. As the pathogenesis of kidney diseases is multifactorial, several experimental models have recently been established to mimic clinical situations and provide a mechanistic understanding of various renal pathologies, with the aim of identifying and developing potential therapeutic targets. These models have been utilized to identify several underlying molecular mechanisms, including the following: the PI3K/Akt/mTOR, Jak/Stat, and inflammatory signaling pathways; the activation of the renal hydrogen sulfide system; the induction of oxidative and endoplasmic reticulum stress and apoptotic pathways; the activation of fibroblasts and the renin-angiotensin-aldosterone system; and mitochondrial dysfunction. Targeting these molecular mechanisms has proven to be beneficial and offers huge potential for developing novel therapies. This Special Issue focuses on recent developments in research on the pathophysiology of kidney diseases and their therapeutic targets for diagnosis and treatment.
Antioxidant Compounds and Health Benefits of Citrus Fruits
This reprint was developed to provide readers with new and interesting studies on the antioxidant effects of citrus fruit constituents. The investigation and identification of the biological properties of these promising antioxidant compounds, as well as their mechanisms of action, can effectively contribute to the development of new pharmaceutical formulations capable of being used therapeutically in a variety of inflammatory diseases. This compilation of articles adds to the already existing literature with important findings on its effects.
Advances in Diagnosis and Treatment of Peritoneum Cancer
Approximately 4-10% of patients with tumors of the abdominal cavity have peritoneal metastasis (PM) at the time of diagnosis, while 20-40% will develop PM during the evolution of their tumor. Until recently, the diagnosis of PM was ominous and associated with severe and incapacitating symptoms, a poor response to systemic chemotherapy, and a poor survival of 4-6 months. The scenario has changed following the introduction of a new generation of chemotherapy and agents against biological targets, as well as with the introduction of new combined therapies, including cytoreductive surgery and new diagnostic-therapeutic schemes. However, there are still many unresolved issues relating to the role, indications, and efficiency that these new therapeutic schemes may offer. We aimed to evaluate the latest knowledge in relation to PM with respect to the incidence, clinical and molecular prognostic factors, survival, and the role of surgical-chemotherapeutic techniques in this era of biological and immunotherapy agents. Special interest had been placed on colorectal, gastric, and ovarian cancer, as well as primary peritoneal cancer.
New Strategies in Preventing Inflammatory and/or Oxidative-Stress-Induced Damages in Ischemia-Reperfusion Injury
This Reprint brings together a set of original articles and reviews that explore the multifaceted nature of ischemia-reperfusion injury, a process central to many acute and chronic conditions. The contributions reflect different perspectives-from basic cellular mechanisms to preclinical models and early clinical observations-offering a broad view of how oxidative stress, inflammation, and mitochondrial dysfunction interact in the pathophysiology of reperfusion injury. Several studies focus on antioxidant-based interventions, ranging from classical molecules to newer therapeutic approaches that modulate endogenous defense systems. Others examine biomarkers, imaging tools, or the timing of intervention as key elements in preventing irreversible damage. Rather than presenting definitive conclusions, the articles collected here underline the complexity of the phenomenon and the challenges that remain. This Reprint may be of interest to those working in experimental medicine, surgery, neuroscience, cardiovascular research, and related disciplines, where reperfusion injury remains a major hurdle to improving outcomes.
